Combination therapy for treating covid-19
AssigneeDrugArray, Inc.
InventorDayu TENG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating coronavirus-associated diseases in an individual comprising administering to the individual an effective amount of peramivir, cidofovir, or nevirapine and an effective amount of a second antiviral agent. Also provided are methods of treating coronavirus-associated diseases in an individual comprising administering to the individual an effective amount of nevirapine and an effective amount of valacyclovir and/or nevirapine. Also provided are formulations and methods of delivering the formulations to an individual.
Claims20
A method of treating an infectious disease in an individual comprising administering to an individual:
- a) an effective amount of peramivir, cidofovir, or nevirapine, and
- b) an effective amount of at least one other antiviral agent, wherein the other antiviral agent is selected from the group consisting of a reverse transcriptase inhibitor, a protease inhibitor, an integrase inhibitor, and a viral DNA polymerase inhibitor.
Dependencies are inferred from the claim text.